Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial

Insulin analogues in type 1 diabetes mellitus: getting better all the time

(2017) Chantal Mathieu et al.   Nature Reviews Endocrinology

Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?

(2016) Sten Madsbad   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Timing of Insulin Injections Predicts Type 2 Diabetes Control and Adherence in a Multinational Sample

(2016) A Nikolajsen et al.   VALUE IN HEALTH

Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience

(2015) Kjeld Hermansen et al.   DRUGS

Evolution of Insulin: From Human to Analog

(2014) Joseph M. Tibaldi   AMERICAN JOURNAL OF MEDICINE

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

(2013) E. R. Seaquist et al.   DIABETES CARE

Guideline for management of postmeal glucose in diabetes

(2013)   DIABETES RESEARCH AND CLINICAL PRACTICE

Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase

(2011) M. Hompesch et al.   DIABETES CARE

Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes

(2010) Y. M. Luijf et al.   DIABETES CARE